Abiopharma

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025

New Form 8-K - X4 Pharmaceuticals, Inc Filed: 2025-08-12 AccNo: 0001628280-25-039770 Size: 917 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item …

CORRECTING and REPLACING: SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available

New Form 4 - AtriCure, Inc. Filed: 2025-08-12 AccNo: 0001230584-25-000003 Size: 6 KB

New Form 8-K - AVITA Medical, Inc. Filed: 2025-08-12 AccNo: 0001762303-25-000023 Size: 353 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Financial Statements and Related Announcement: Second Quarter and/ or Half Yearly Results

New Form 6-K - IM Cannabis Corp. Filed: 2025-08-12 AccNo: 0001178913-25-002780 Size: 8 MB

New Form SCHEDULE 13G/A - SenesTech, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003495 Size: 11 KB

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions

New Form 8-K - Autolus Therapeutics plc Filed: 2025-08-12 AccNo: 0001730463-25-000064 Size: 4 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Aprea Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001558370-25-011152 Size: 4 MB

New Form 8-K - Taysha Gene Therapies, Inc. Filed: 2025-08-12 AccNo: 0001193125-25-178504 Size: 244 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Coya Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106934 Size: 7 MB